Published in Lancet on July 22, 1989
Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. JAMA (2012) 2.66
Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev (2004) 2.05
Restenosis after coronary angioplasty: a proposal of new comparative approaches based on quantitative angiography. Br Heart J (1992) 1.21
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord (2010) 1.02
The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design. Am Heart J (2011) 0.99
Fish oils and cardiovascular disease. BMJ (1995) 0.93
Fish oil versus olive oil. Lancet (1990) 0.78
Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty. Tex Heart Inst J (1992) 0.77
Antiatherogenic effects of n-3 fatty acids - evidence and mechanisms. Heart Int (2006) 0.77
Fish oil and ischaemic heart disease. Br Heart J (1993) 0.76
The effects of aspirin on platelet function and lysophosphatidic acids depend on plasma concentrations of EPA and DHA. Prostaglandins Leukot Essent Fatty Acids (2014) 0.76
Antiplatelet therapy--Part II. West J Med (1993) 0.75
Fish oil and coronary angioplasty. Lancet (1989) 0.75
Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases. Drugs (1991) 0.75
A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med (1997) 19.93
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA (2000) 12.86
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med (1994) 7.96
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med (1996) 6.92
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med (1991) 6.13
Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest (1975) 5.72
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med (2001) 5.50
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation (2000) 5.15
Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr (1999) 5.12
A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med (1998) 4.68
Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA (1994) 4.64
TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation (1996) 4.41
Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res (1987) 3.86
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA (1996) 3.69
Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann Intern Med (2001) 3.56
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr (2001) 3.12
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation (2000) 2.93
Paradoxical embolism. Diagnosis during life. Am J Med (1972) 2.85
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.80
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy. Lancet (2001) 2.78
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation (2001) 2.73
Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med (1991) 2.68
Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68
Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men. Am J Epidemiol (1992) 2.68
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med (1993) 2.55
Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol (1995) 2.52
Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med (1997) 2.48
Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. N Engl J Med (1990) 2.37
The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med (2000) 2.34
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. Eur Heart J (2001) 2.28
The relation between dietary intake and adipose tissue composition of selected fatty acids in US women. Am J Clin Nutr (1998) 2.24
Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation (1991) 2.23
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Subclavian venous catheterization: greater success rate for less experienced operators using ultrasound guidance. Crit Care Med (1995) 2.22
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22
Evidence implicating nonmuscle myosin in restenosis. Use of in situ hybridization to analyze human vascular lesions obtained by directional atherectomy. Circulation (1992) 2.20
Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol (1993) 2.18
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation (1999) 2.16
Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst (1993) 2.15
Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? Ann Intern Med (1992) 2.11
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA (2001) 2.07
The creatine kinase system in normal and diseased human myocardium. N Engl J Med (1985) 2.06
Transcatheter closure of ventricular septal defects. Circulation (1988) 2.05
Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Ann Intern Med (1996) 2.03
Extravasation of thrombus into the aortic root: a complication following use of an infusion catheter for intragraft thrombolysis. Cathet Cardiovasc Diagn (1996) 2.03
Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med (1978) 2.03
Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation (1990) 2.01
Balloon dilatation of calcific aortic stenosis in elderly patients: postmortem, intraoperative, and percutaneous valvuloplasty studies. Circulation (1986) 2.00
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA (1996) 1.99
Atrial ejection force: a noninvasive assessment of atrial systolic function. J Am Coll Cardiol (1993) 1.99
Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation (1994) 1.98
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol (1998) 1.96
Transcatheter closure of coronary artery fistulas. J Am Coll Cardiol (1992) 1.93
Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. N Engl J Med (1992) 1.92
Reflex increase in coronary vascular resistance in patients with ischemic heart disease. N Engl J Med (1976) 1.92
Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol (1984) 1.91
Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab (1997) 1.88
Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med (1980) 1.87
Cardiovascular disease in women. Circulation (1993) 1.87
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation (1999) 1.83
Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Cathet Cardiovasc Diagn (1992) 1.82
Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary-artery disease in the Coronary Artery Surgery Study (CASS). N Engl J Med (1979) 1.79
The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med (1999) 1.78
Fatty acid composition of subcutaneous adipose tissue and diet in postmenopausal US women. Am J Clin Nutr (1991) 1.78
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation (1987) 1.78
Contractile state of the left ventricle in man as evaluated from end-systolic pressure-volume relations. Circulation (1977) 1.77
Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA (2001) 1.75
A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA (1999) 1.74
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J (2002) 1.73
Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation (1990) 1.73
Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplant (2008) 1.72
Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol (1998) 1.68
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67
Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol (1996) 1.65
Percutaneous balloon mitral valvuloplasty in a pregnant woman with mitral stenosis. Cathet Cardiovasc Diagn (1988) 1.65
Origin of the left main coronary artery from the "non-coronary" sinus of Valsalva. Cathet Cardiovasc Diagn (1991) 1.65
Prognostic significance of angiographically documented left ventricular aneurysm from the Coronary Artery Surgery Study (CASS). Am J Cardiol (1982) 1.65
Effects of short-term treatment of hyperlipidemia on coronary vasodilator function and myocardial perfusion in regions having substantial impairment of baseline dilator reverse. Circulation (1998) 1.64
Mechanical debulking versus balloon angioplasty for the treatment of true bifurcation lesions. J Am Coll Cardiol (1998) 1.61
Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol (1994) 1.61
Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. Am J Cardiol (2001) 1.60
Diastolic properties of the left ventricle. Ann Intern Med (1976) 1.59
Plasma lipids and lipoproteins in vegetarians and controls. N Engl J Med (1975) 1.59
Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem (1989) 1.58
Chewing the fat--how much and what kind? N Engl J Med (1991) 1.57
Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol (1993) 1.53
Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol (1988) 1.51
Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer (1999) 1.50